QS Investors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $2M | Sell |
5,767
-26
| -0.4% | -$7.88K | 0.02% | 353 |
|
|
2021
Q1 | $1.62M | Sell |
5,793
-34,749
| -86% | -$9.37M | 0.02% | 398 |
|
|
2020
Q4 | $9.93M | Sell |
40,542
-143
| -0.4% | -$36.9K | 0.12% | 137 |
|
|
2020
Q3 | $11.5M | Buy |
40,685
+50
| +0.1% | +$13.9K | 0.15% | 114 |
|
|
2020
Q2 | $10.9M | Sell |
40,635
-7,294
| -15% | -$2.19M | 0.15% | 118 |
|
|
2020
Q1 | $15.2M | Sell |
47,929
-5,509
| -10% | -$1.67M | 0.24% | 68 |
|
|
2019
Q4 | $15.7M | Buy |
53,438
+1,240
| +2% | +$344K | 0.16% | 94 |
|
|
2019
Q3 | $12.2M | Buy |
52,198
+15,436
| +42% | +$3.59M | 0.13% | 119 |
|
|
2019
Q2 | $8.6M | Buy |
36,762
+1,630
| +5% | +$376K | 0.09% | 144 |
|
|
2019
Q1 | $8.3M | Buy |
35,132
+1,743
| +5% | +$549K | 0.09% | 146 |
|
|
2018
Q4 | $10M | Sell |
33,389
-5,079
| -13% | -$1.62M | 0.13% | 112 |
|
|
2018
Q3 | $13.6M | Sell |
38,468
-963
| -2% | -$332K | 0.13% | 114 |
|
|
2018
Q2 | $11.4M | Hold |
39,431
| – | – | 0.11% | 122 |
|
|
2018
Q1 | $10.8M | Sell |
39,431
-224
| -0.6% | -$69.5K | 0.11% | 116 |
|
|
2017
Q4 | $12.6M | Sell |
39,655
-8,752
| -18% | -$2.81M | 0.12% | 106 |
|
|
2017
Q3 | $15.2M | Sell |
48,407
-4,758
| -9% | -$1.41M | 0.12% | 99 |
|
|
2017
Q2 | $14.4M | Sell |
53,165
-301
| -0.6% | -$79.6K | 0.12% | 97 |
|
|
2017
Q1 | $14.6M | Sell |
53,466
-15,629
| -23% | -$4.42M | 0.13% | 99 |
|
|
2016
Q4 | $19.6M | Buy |
69,095
+1,984
| +3% | +$588K | 0.16% | 103 |
|
|
2016
Q3 | $21M | Sell |
67,111
-563
| -0.8% | -$167K | 0.16% | 102 |
|
|
2016
Q2 | $16.4M | Sell |
67,674
-1,543
| -2% | -$407K | 0.14% | 130 |
|
|
2016
Q1 | $18M | Buy |
69,217
+128
| +0.2% | +$33.8K | 0.17% | 113 |
|
|
2015
Q4 | $21.2M | Buy |
69,089
+8,461
| +14% | +$2.43M | 0.2% | 95 |
|
|
2015
Q3 | $17.7M | Sell |
60,628
-1,575
| -3% | -$520K | 0.19% | 101 |
|
|
2015
Q2 | $25.1M | Sell |
62,203
-65,747
| -51% | -$26.4M | 0.31% | 68 |
|
|
2015
Q1 | $54M | Sell |
127,950
-17,401
| -12% | -$6.86M | 0.61% | 23 |
|
|
2014
Q4 | $49.3M | Buy |
145,351
+133,588
| +1,136% | +$43.2M | 0.57% | 26 |
|
|
2014
Q3 | $3.89M | Sell |
11,763
-1,150
| -9% | -$379K | 0.1% | 165 |
|
|
2014
Q2 | $4.07M | Sell |
12,913
-15,965
| -55% | -$4.81M | 0.11% | 177 |
|
|
2014
Q1 | $8.83M | Sell |
28,878
-29,300
| -50% | -$9.3M | 0.27% | 98 |
|
|
2013
Q4 | $16.3M | Buy |
58,178
+3,575
| +7% | +$925K | 0.62% | 41 |
|
|
2013
Q3 | $13.1M | Sell |
54,603
-25,222
| -32% | -$5.64M | 0.57% | 53 |
|
|
2013
Q2 | $17.2M | Buy |
+79,825
| New | +$17.1M | 0.6% | 40 |
|
Other funds holding BIIB
QS Investors's BIIB Position: Q2 2021 in Review
QS Investors reduced its Biogen (BIIB) stake by 0.45% in Q2 2021, selling an estimated $7.88K and leaving 5,767 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #353.
QS Investors first reported a position in BIIB in Q2 2013 and has held it in 33 quarters since. The position peaked at $54M in Q1 2015. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.
- QS Investors held 5,767 shares of Biogen worth $2M as of Q2 2021.
- QS Investors sold 26 Biogen shares in Q2 2021, an estimated $7.88K.
- Biogen made up 0.02% of QS Investors's portfolio in Q2 2021, its #353 holding.
- QS Investors first reported a position in Biogen in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Biogen position peaked at $54M in Q1 2015.
- 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.